- Home
- JTAI vs SBFM Comparison
JTAI vs SBFM Comparison
Compare JTAI & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JTAI
- SBFM
- Stock Information
- Founded
- JTAI 2018
- SBFM 2006
- Country
- JTAI United States
- SBFM United States
- Employees
- JTAI N/A
- SBFM N/A
- Industry
- JTAI Blank Checks
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- JTAI Finance
- SBFM Health Care
- Exchange
- JTAI Nasdaq
- SBFM Nasdaq
- Market Cap
- JTAI 9.9M
- SBFM 6.7M
- IPO Year
- JTAI N/A
- SBFM N/A
- Fundamental
- Price
- JTAI $3.58
- SBFM $1.51
- Analyst Decision
- JTAI
- SBFM Strong Buy
- Analyst Count
- JTAI 0
- SBFM 1
- Target Price
- JTAI N/A
- SBFM $15.00
- AVG Volume (30 Days)
- JTAI 201.6K
- SBFM 192.4K
- Earning Date
- JTAI 08-13-2025
- SBFM 08-15-2025
- Dividend Yield
- JTAI N/A
- SBFM N/A
- EPS Growth
- JTAI N/A
- SBFM N/A
- EPS
- JTAI N/A
- SBFM N/A
- Revenue
- JTAI $13,648,668.00
- SBFM $36,234,578.00
- Revenue This Year
- JTAI $13.37
- SBFM $192.48
- Revenue Next Year
- JTAI $201.13
- SBFM N/A
- P/E Ratio
- JTAI N/A
- SBFM N/A
- Revenue Growth
- JTAI N/A
- SBFM 35.51
- 52 Week Low
- JTAI $2.30
- SBFM $1.17
- 52 Week High
- JTAI $97.40
- SBFM $6.99
- Technical
- Relative Strength Index (RSI)
- JTAI 46.53
- SBFM 49.86
- Support Level
- JTAI $3.33
- SBFM $1.43
- Resistance Level
- JTAI $3.75
- SBFM $1.61
- Average True Range (ATR)
- JTAI 0.17
- SBFM 0.12
- MACD
- JTAI 0.03
- SBFM 0.00
- Stochastic Oscillator
- JTAI 49.64
- SBFM 32.78
About JTAI Jet.AI Inc.
Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.